Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the …

LB Goldstein, R Adams, MJ Alberts, LJ Appel, LM Brass… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—This guideline provides an overview of the evidence on various
established and potential stroke risk factors and provides recommendations for the reduction …

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease

GGL Biondi-Zoccai, M Lotrionte, P Agostoni… - European heart …, 2006 - academic.oup.com
Aims The role of aspirin in patients with coronary artery disease (CAD) is well established,
yet patients happen to discontinue aspirin according to physician's advice or unsupervised …

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

JS Berger, MC Roncaglioni, F Avanzini, I Pangrazzi… - Jama, 2006 - jamanetwork.com
ContextAspirin therapy reduces the risk of cardiovascular disease in adults who are at
increased risk. However, it is unclear if women derive the same benefit as men. ObjectiveTo …

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years

R Carandang, S Seshadri, A Beiser, M Kelly-Hayes… - Jama, 2006 - jamanetwork.com
ContextPrior estimates of long-term trends in the incidence and severity of stroke have
varied; trends in lifetime risk have not been reported. ObjectiveTo determine long-term …

Migraine and risk of cardiovascular disease in women

T Kurth, JM Gaziano, NR Cook, G Logroscino… - Jama, 2006 - jamanetwork.com
ContextMigraine with aura has been associated with an adverse cardiovascular risk profile
and prothrombotic factors that, along with migraine-specific physiology, may increase the …

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

KR McQuaid, L Laine - The American journal of medicine, 2006 - Elsevier
PURPOSE: We performed a systematic review to define the relative and absolute risk of
clinically relevant adverse events with the antiplatelet agents, aspirin and clopidogrel …

[PDF][PDF] Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

M Stramba-Badiale, KM Fox, SG Priori… - European heart …, 2006 - academic.oup.com
Cardiovascular diseases (CVD) are the leading cause of mortality both in men and women.
In Europe, about 55% of all females' deaths are caused by CVD, especially coronary heart …

Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women

S Mora, IM Lee, JE Buring, PM Ridker - Jama, 2006 - jamanetwork.com
ContextThere are few data directly comparing the effects of physical activity and body weight
on cardiovascular biomarkers. ObjectiveTo examine the association of physical activity and …

The effect of including C-reactive protein in cardiovascular risk prediction models for women

NR Cook, JE Buring, PM Ridker - Annals of internal medicine, 2006 - acpjournals.org
Background: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor
of cardiovascular risk, global risk prediction models incorporating hsCRP have not been …

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

EI Lev, RT Patel, KJ Maresh, S Guthikonda… - Journal of the American …, 2006 - jacc.org
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary
Intervention: The Role of Dual Drug Resistance Eli I. Lev, Rajnikant T. Patel, Kelly J. Maresh …